Prudential Financial
COGT icon

Prudential Financial’s Cogent Biosciences COGT Stock Holding History

Prudential Financial’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.55M Sell
143,495
-34,670
-19% -$1.21M 0.01% 941
2026
Q1 		$6.86M Buy
178,165
+57,990
+48% +$2.14M 0.01% 781
2025
Q4 		$4.27M Buy
120,175
+104,780
+681% +$2.95M 0.01% 990
2025
Q3 		$221K Buy
15,395
+2,490
+19% +$29.5K ﹤0.01% 2192
2025
Q2 		$92.7K Buy
+12,905
New +$71.5K ﹤0.01% 2295

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Prudential Financial's COGT Position: Q2 2026 in Review

Prudential Financial reduced its Cogent Biosciences (COGT) stake by 19% in Q2 2026, selling an estimated $1.21M and leaving 143,495 shares worth $5.55M. The position accounts for 0.01% of the portfolio, ranked #941.

Prudential Financial first reported a position in COGT in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.86M in Q1 2026. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Prudential Financial held 143,495 shares of Cogent Biosciences worth $5.55M as of Q2 2026.
  • Prudential Financial sold 34,670 Cogent Biosciences shares in Q2 2026, an estimated $1.21M.
  • Cogent Biosciences made up 0.01% of Prudential Financial's portfolio in Q2 2026, its #941 holding.
  • Prudential Financial first reported a position in Cogent Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Prudential Financial's Cogent Biosciences position peaked at $6.86M in Q1 2026.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.